Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (2): 203-208. doi: 10.19723/j.issn.1671-167X.2022.02.001
DING Ting-ting,ZENG Chu-xiong,HU Li-na,YU Ming-hua()
CLC Number:
[1] |
Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(3):177-193.
doi: 10.3322/caac.21395 |
[2] | Shibutani M, Maeda K, Nagahara H, et al. Tumor-infiltrating lymphocytes predict the chemotherapeutic outcomes in patients with stage Ⅳ colorectal cancer[J]. In Vivo, 2018, 32(1):151-158. |
[3] |
Guinney J, Dienstmann R, Wang X, et al. The consensus mole-cular subtypes of colorectal cancer[J]. Nat Med, 2015, 21(11):1350-1356.
doi: 10.1038/nm.3967 pmid: 26457759 |
[4] |
Church J. Molecular genetics of colorectal cancer[J]. Sem Colon Rectal Surg, 2016, 27(4):172-175.
doi: 10.1053/j.scrs.2016.04.013 |
[5] |
Bremnes RM, Al-Shibli K, Donnem T, et al. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: Emphasis on non-small cell lung cancer[J]. J Thorac Oncol, 2011, 6(4):824-833.
doi: 10.1097/JTO.0b013e3182037b76 pmid: 21173711 |
[6] |
Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: New findings and future perspectives[J]. Mol Cancer, 2021, 20(1):131-142.
doi: 10.1186/s12943-021-01428-1 |
[7] |
Baxevanis CN, Papamichail M, Perez SA. Immune classification of colorectal cancer patients: Impressive but how complete?[J]. Expert Opin Biol Ther, 2013, 13(4):517-526.
doi: 10.1517/14712598.2013.751971 |
[8] |
Grizzi F, Basso G, Borroni EM, et al. Evolving notions on immune response in colorectal cancer and their implications for biomarker developmentc[J]. Inflamm Res, 2018, 67(5):375-389.
doi: 10.1007/s00011-017-1128-1 pmid: 29322204 |
[9] |
Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles[J]. Nat Methods, 2015, 12(5):453-457.
doi: 10.1038/nmeth.3337 pmid: 25822800 |
[10] |
Liu X, Wu S, Yang Y, et al. The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer[J]. Biomed Pharmacother, 2017, 95:55-61.
doi: 10.1016/j.biopha.2017.08.003 |
[11] |
Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis[J]. Nat Med, 2013, 19(11):1423-1437.
doi: 10.1038/nm.3394 |
[12] |
Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer[J]. Trends Cell Biol, 2015, 25(4):198-213.
doi: 10.1016/j.tcb.2014.11.006 |
[13] |
Anitei MG, Zeitoun G, Mlecnik B, et al. Prognostic and predictive values of the immunoscore in patients with rectal cancer[J]. Clin Cancer Res, 2014, 20(7):1891-1899.
doi: 10.1158/1078-0432.CCR-13-2830 |
[14] |
Huh JW, Lee JH, Kim HR. Prognostic significance of tumorinfiltrating lymphocytes for patients with colorectal cancer[J]. Arch Surg, 2012, 147(4):366-372.
doi: 10.1001/archsurg.2012.35 |
[15] |
Karpinski P, Rossowska J, Sasiadek MM. Immunological landscape of consensus clusters in colorectal cancer[J]. Oncotarget, 2017, 8(62):105299-105311.
doi: 10.18632/oncotarget.v8i62 |
[16] |
Mirjolet C, Charon-Barra C, Ladoire S, et al. Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study[J]. Oncoimmunology, 2018, 7(3):e1396402.
doi: 10.1080/2162402X.2017.1396402 |
[17] |
Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome[J]. Science, 2006, 313(5759):1960-1964.
doi: 10.1126/science.1129139 |
[18] |
Klintrup K, Makinen JM, Kauppila S, et al. Inflammation and prognosis in colorectal cancer[J]. Eur J Cancer, 2005, 41(17):2645-2654.
doi: 10.1016/j.ejca.2005.07.017 pmid: 16239109 |
[19] |
Li T, Fan J, Wang B, et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res, 2017, 77(21):e108-e110.
doi: 10.1158/0008-5472.CAN-17-0307 |
[20] |
Pagès F, Mlecnik B, Marliot F, et al. International validation of the consensus immunoscore for the classification of colon cancer: A prognostic and accuracy study[J]. Lancet, 2018, 391(10135):2128-2139.
doi: 10.1016/S0140-6736(18)30789-X |
[21] |
Steinman RM. Decisions about dendritic cells: Past, present, and future[J/OL]. Annu Rev Immunol, 2012, 30:1-22. doi: 10.1146/annurevimmunol-100311-102839.
doi: 10.1146/annurevimmunol-100311-102839 |
[22] |
Shimizu K, Kotera Y, Aruga A, et al. Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma[J]. Hum Vaccin Immunother, 2014, 10(4):970-976.
doi: 10.4161/hv.27678 |
[23] | Pagès F, Kirilovsky A, Mlecnik B, et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer[J]. J Clin Oncol, 2009, 27(35):5944-5951. |
[24] |
Gannon PO, Baumgaertner P, Huber A, et al. Rapid and continued T-cell differentiation into long-term effector and memory stem cells in vaccinated melanoma patients[J]. Clin Cancer Res, 2017, 23(13):3285-3296.
doi: 10.1158/1078-0432.CCR-16-1708 |
[1] | TIAN Jia-yi,ZHANG Xia,CHENG Gong,LIU Qing-hong,WANG Shi-yang,HE Jing. Serum interleukin-2 receptor α as a clinical biomarker in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1083-1087. |
[2] | MA Xiang-bo,ZHANG Xue-wu,JIA Ru-lin,GAO Ying,LIU Hong-jiang,LIU Yu-fang,LI Ying-ni. Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 721-727. |
[3] | Wen-peng WANG,Jie-fu WANG,Jun HU,Jun-feng WANG,Jia LIU,Da-lu KONG,Jian LI. Clinicopathological features and prognosis of colorectal stromal tumor [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 353-361. |
[4] | Xu-chu ZHANG,Jian-hua ZHANG,Rong-fu WANG,Yan FAN,Zhan-li FU,Ping YAN,Guang-yu ZHAO,Yan-xia BAI. Diagnostic value of 18F-FDG PET/CT and tumor markers (CEA, CA19-9, CA24-2) in recurrence and metastasis of postoperative colorectal moderately differentiated adenocarcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1071-1077. |
[5] | Yu-bing XIAO,Mu-yao GUO,Xiao-xia ZUO. Immunometabolism and systemic lupus erythematosus [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1120-1124. |
[6] | ZHOU Jian-hua, WANG Di, WANG Huan-rui, HOU Xiao-li,YU Wei-dong, XU Ke-xin, HU Hao. Cytotoxic effects of γδT cells on bladder cancer cells and expression of MICA/B in bladder cancer [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 595-601. |
[7] | LIU Yu-qing, LU Jian, HAO Yi-chang, XIAO Chun-lei, MA Lu-lin. Predicting model based on risk factors for urosepsis after percutaneous nephrolithotomy [J]. Journal of Peking University(Health Sciences), 2018, 50(3): 507-513. |
[8] | LIU Jing-wei, LU Xu, YANG Zhao-min, DENG Li-juan, YANG Lin. Immune effects of specific CTLs response induced by dendritic cells pulsed with NY-ESO-1 peptide [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 840-846. |
[9] | LIU En-yang, LIU Jing-fang, SHAO Wen-wei, XIAO Lin, LI Guo-hui, CHANG Xiao-hong, QIU Xiao-yan. Tumor derived IgG suppress the proliferation of T cells in cord blood [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 824-828. |
[10] | CHEN Wei, HU Fan-lei, LIU Hong-jiang, XU Li-ling, LI Ying-ni, LI Zhan-guo. Myeloid-derived suppressor cells promoted autologous B cell proliferation in rheumatoid arthritis [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 819-823. |
[11] | CHEN Yang, WANG Yan-rong, SHI Yan, DAI Guang-hai. Prognostic value of chemotherapy-induced neutropenia in metastatic colon cancer patients undergoing first-line chemotherapy with FOLFOX [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 669-674. |
[12] | LIU Yan-xia, YANG Xue-song, FU Wei, YAO Hong-wei. Association of single nucleotide polymorphism rs6983267 with ulcerative colitis and colorectal cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 994-999. |
[13] | CHEN Xiao-mei, LI Jing, ZHANG Xiao-ying, JIN Yue-bo, YU Di, SUN Xiao-lin,WU Li-jun, HE Jing, LI Zhan-guo. Significance of different T follicular helper subsets in rheumatoid arthritis [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 958-963. |
[14] | AN Le-mei, LI Juan, JI Lan-lan, LI Guang-tao, ZHANG Zhuo-li. Detection of peripheral follicular helper T cells in rheumatoid arthritis [J]. Journal of Peking University(Health Sciences), 2016, 48(6): 951-957. |
[15] | SHI Lian-jie, LI Jian-hong, HU Fan-lei, LI Min, ZHANG Jie, LI Jiang-tao, LI Zhan-guo. Clinical significance of serum C-C chemokine ligand 19 levels in patients with rheumatoid arthritis [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 667-671. |
|